jelaco
7 months ago
Dec 23 Q out....a couple interesting notes in the filing:
On February 16, 2024, the Company submitted a new provisional patent application to the USPTO covering new active pharmaceutical ingredients. The registration change has yet to be updated and still remains showing being registered to the former patent holder. The additional information with respect to this new filing will be made available in the near future once official registrations have been properly updated.
On December 16, 2022, the Company announced it has applied for name and symbol change to reflect its new name of ALZEX NEUROPHARMA INC. and is awaiting final approval from FINRA of its Corporate Action